Retro
Retro is on a mission to add 10 years to healthy human lifespan.
Challenge
How do you support the building of a generational pharma company developing therapies for diseases driven by the biology of aging?
Approach
Retro is starting with cellular reprogramming, autophagy and plasma-inspired therapeutics. To learn more, read the company’s announcement and MIT Technology Review’s exclusive story here describing the company as the “OpenAI for longevity.”
“We don’t want therapies that are super expensive and awkward and difficult to implement.”
Joe Betts-LaCroix – Co-founder and CEO of Retro Biosciences
